GTGüven Toksoy

Güven Toksoy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Güven Toksoy has a total of 219 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Long-term growth and growth hormone treatment in CSGALNACT1-related skeletal dysplasia: three siblings with a novel homozygous nonsense variant

    by Cansu Koc, Asli Derya Kardelen Al, Hasan Yanik, Mehmet Akif Yucesoy, Melek Yildiz, Sukran Poyrazoglu, Volkan Karaman, Ayca Dilruba Aslanger, Guven Toksoy, Feyza Darendeliler, et al.

    Biallelic CSGALNACT1 variants impair chondroitin sulfate biosynthesis and cause a rare skeletal dysplasia. Longitudinal growth data and experience with recombinant human growth hormone (rhGH) remain limited. We describe three siblings of consanguineous parents with a homozygous nonsense variant, c.429T>G, p.(Tyr143*). All three had prenatal limb shortening, disproportionate short stature, joint hypermobility, skin hyperextensibility, and mild skeletal abnormalities. Exome sequencing identified the variant in the index patient, and Sanger sequencing confirmed segregation in the family. The siblings received rhGH for 8.1-12.2 years, with treatment initiated before molecular diagnosis under different endocrine indications. Height standard deviation scores increased by 0.61, 1.87, and 1.39 from treatment initiation to the last assessment, respectively. First-year gains were limited in two siblings. At the last assessment, the eldest sibling had discontinued treatment, whereas the other two remained on rhGH. No slipped capital femoral epiphysis or progression of scoliosis was documented. Bone age was concordant with chronological age at the latest assessment in all three; infant hand-wrist radiographs were unavailable. These observations extend the longitudinal clinical description of CSGALNACT1-related skeletal dysplasia but do not establish disease-specific rhGH efficacy or general safety. Molecular diagnosis can inform reassessment of treatment indications. Normal bone age later in childhood should not preclude genetic evaluation when disproportionate short stature and joint hypermobility suggest an underlying skeletal disorder.

  • Evaluating dental developmental abnormalities in osteogenesis imperfecta: associations with timing and cumulative exposure to intravenous pamidronate- a pilot study

    by Kübra Demir, Aslı Derya Kardelen, Ayça Aslanger, Cansu Koç, Ayşe Pınar Öztürk, Çağrı Güleç, Firdevs Baş, Elif Bahar Tuna İnCe, Güven Toksoy

  • Open Access

    Assessment of cardiometabolic risk using single point insulin sensitivity estimator (SPISE) in pediatric Bardet–Biedl Syndrome: a pilot study

    by Tugce Kandemir, Melek Yildiz, Ummahan Tercan, Ozge Bayrak Demirel, Hasan Yanik, Volkan Karaman, Ayca Dilruba Aslanger, Aslı Derya Kardelen, Sukran Poyrazoglu, Feyza Darendeliler, et al.

    Background: Bardet-Biedl syndrome (BBS) carries early cardiometabolic risk, yet pediatric screening is complicated by growth and puberty. The metabolic syndrome (MetS) z-score provides a continuous benchmark for clustered risk. The single-point insulin sensitivity estimator (SPISE), based on body mass index (BMI) and fasting lipids, may offer a practical alternative where insulin testing is impractical. We aimed to assess the association between SPISE and cardiometabolic burden in children with molecularly confirmed BBS, and to compare its ability to identify MetS against the MetS z-score benchmark and insulin-derived indices. Methods: Single-center retrospective pilot study including children/adolescents with genetically confirmed BBS who underwent standardized anthropometry and metabolic profiling (fasting lipids, glucose, insulin; OGTT when available). SPISE–MetS z-score associations were examined using Spearman and adjusted analyses. In adolescents (≥ 10 years), MetS discrimination was evaluated with ROC curves for SPISE, TG/HDL, and homeostatic model assessment for insulin resistance (HOMA-IR), with pairwise DeLong comparisons and Youden-optimal thresholds. Results: Fourteen participants (7 females, 7 males) were evaluated. Median age at last visit was 11.7 years [IQR 7.6–15.5]; BMI SDS was 3.05 [2.47–3.57]. The median MetS z-score was 1.60 [0.90–1.75]. SPISE correlated inversely with the MetS z-score (ρ=-0.57, p = 0.021), and adjusted models (age, sex, BMI-SDS) retained significance. Among adolescents ( n = 10), SPISE showed the highest AUC for MetS (AUC 0.95; 95% CI 0.82–1.00) versus TG/HDL (AUC 0.81) and HOMA-IR (AUC 0.60); pairwise differences were not statistically significant. Youden-optimal SPISE ≤ 3.34 identified MetS with high sensitivity in adolescents. Confidence intervals were wide, reflecting the small sample size. Conclusions: In this single-center pediatric BBS cohort, SPISE tracked continuous MetS burden and showed numerically stronger discrimination for MetS than insulin-derived indices. These findings highlight the potential utility of SPISE as a feasible tool for cardiometabolic monitoring in syndromic obesity, where laboratory access may be limited. Beyond BBS, SPISE may support early risk stratification and follow-up in rare obesity models of metabolic risk, but multicenter prospective validation remains warranted.

  • Clinical and Molecular Characterization of a RASopathy Cohort From Türkiye and an AMMECR1 ‐Related Noonan Syndrome‐Mimicking Phenotype

    by Esma Nur Konur Akbaş, Güven Toksoy, Şahin Avcı, Umut Altunoğlu, Tuğba Kalaycı, Gözde Yeşil Sayın, Hülya Kayserili, Zehra Oya Uyguner, Ayça Dilruba Aslanger

    RASopathies comprise a group of congenital malformation syndromes with predominant neuro‐cardio‐facial‐cutaneous involvement resulting from pathogenic variants in RAS/mitogen‐activated protein kinase (MAPK) signaling pathway genes. In this study 33 patients are presented with their clinical and molecular findings as an RASopathy cohort including a family with an AMMECR1 ‐related disorder. The diagnostic distribution of the cohort included Noonan syndrome ( n = 18), neurofibromatosis type 1 ( n = 8), and single cases of cardiofaciocutaneous syndrome, Costello syndrome, neurofibromatosis‐Noonan syndrome, NF1 microdeletion syndrome, Noonan syndrome‐like disorder with loose anagen hair, Noonan syndrome with multiple lentigines and AMMECR1 ‐related midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis (MIM# 300990). The most prevalent clinical manifestations were dermatological findings (90.9%), skeletal features (84.4%), cardiovascular involvement (75.8%), and typical craniofacial dysmorphism suggestive of RASopathy (72.7%). Variants were most frequently identified in PTPN11 and NF1 , followed by single cases involving the BRAF , HRAS , LZTR1 , RAF1 , RIT1 , SHOC2 , and SOS1 . Notably, one patient harbored a variant in AMMECR1 , which is not involved in the RAS/MAPK pathway. Overall, this study delineates the clinical and molecular landscape of a cohort from Türkiye and underscores that the AMMECR1 ‐related phenotype represents a distinct entity that closely mimics Noonan syndrome.

  • Evaluation of the Impact of a PUS7 Gene Variant on Dental Development: A Rare Case Report

    by Büşra Karaduran, Gülhanım Memiş, Canberk Toprak, Volkan Karaman, Mine Koruyucu, Ayça Dilruba Aslanger, Güven Toksoy, Zehra Oya Uyguner

    Introduction: Pseudouridylation, the enzymatic isomerization of uridine to pseudouridine, is a widespread posttranscriptional RNA modification that contributes to RNA stability and regulation of gene expression. The PUS7 gene encodes pseudouridine synthase 7 (PUS7), and its biallelic pathogenic variants have been associated with a syndromic neurodevelopmental disorder characterized by intellectual disability, microcephaly, behavioral abnormalities, growth retardation, and facial dysmorphism. Recent data indicate that PUS7 interacts with SIRT1, a key regulator of the Wnt/β-catenin signaling pathway, suggesting that PUS7 dysfunction may indirectly influence odontogenesis. Case Presentation: We report a boy patient born to consanguineous parents, in whom exome sequencing identified a novel homozygous truncating variant in PUS7 (NM_019042.5): c.1097_1098del p.(Leu366Glnfs*7). Clinical assessment revealed neurodevelopmental delay, facial dysmorphism, and dental anomalies. At 28 months of age, the mandibular primary lateral incisors (72 and 82) were absent, whereas the mandibular central incisors exhibited a conical morphology. Conclusion: Although dental anomalies have been reported in PUS7-related disorders, the abnormalities may be overlooked in children with neuromotor delay. Conical teeth appear to be a more distinctive and clinically recognizable feature, as observed in our patient. Further studies are needed to clarify the role of PUS7 variants in dental development and genotype – phenotype correlations.

  • Small Head Circumference and Height above Target Height as Potential Early Clues for Klinefelter Syndrome: A Retrospective Cohort Study

    by Aslı Kardelen Al, Deniz Özbay Öner, Özge Bayrak Demirel, Nur Şükür, Melek Yıldız, Şükran Poyrazoğlu, Ayça Aslanger, Tuğba Kalaycı, Güven Toksoy, Birsen Karaman, et al.

    Background: Klinefelter syndrome (KS) is often underdiagnosed in childhood due to subtle phenotypic features.Aim: This study aimed to evaluate body measurements and proportions in patients with KS and explore the diagnostic value of auxological findings in early-lifeMethods: This retrospective observational cohort study included 16 patients with KS confirmed by lymphocyte karyotyping. Anthropometric measurements were performed by a single observer using standardized methods. Standard deviation scores (SDS) for height, weight, body mass index (BMI), head circumference (HC), sitting height (SH), and sitting height/height ratio (SHR) were calculated using national reference data. The leg proportions were evaluated using the Manouvrier’s skelic index.Results: At presentation, all patients were prepubertal. The median age was 4.3 (0.1 to 12.7) years and the median SDS values for height, weight, BMI, and HC were −0.3, −0.8, −0.5, and −1.3, respectively. Tall stature was observed in 19% of patients and small HC in 25%. SH was normal, but SHR was low. At the final evaluation, the median age was 12 years (5.2–20.3), and the height was 0.6 SDS (1.6 to 2.0); 6% had a tall stature. The SHR improved, the arm span–height difference was normal, and the final height–target height difference was 1.6 SDS (1.1 to 3.1). Small HC persisted in 25%. Long legs were present in 37.5%.Conclusion: Although the height SDS was normal, the difference from the target height was significant. Small HC—a feature not previously reported in KS—was also frequent. In children taller than the target height with long legs and small HC, KS should be considered.

  • Investigation of oral health findings and genotype correlations in osteogenesis imperfecta

    by Kübra Demir, Çağrı Güleç, Ayça Aslanger, Ayşe Pınar Öztürk, Bilge Özsait Selçuk, Elif Bahar Tuna İnCe, Güven Toksoy

    Osteogenesis imperfecta, a common genetic connective tissue disorder affecting bone with multisystemic implications, is caused by genomic alterations at various levels that disrupt the biosynthesis stages of collagen Type I. This study evaluated the intraoral and clinical findings of 43 OI cases in relation to genetic variants, aiming to contribute new insights into the roles of collagen and non-collagen genes in the oral-dental pathology of OI. Significant associations were found between OI variants and dental anomalies such as dentinogenesis imperfecta, enamel hypoplasia, taurodontism, and hypodontia. COL1A1/2-truncated variants were linked to atypical intercanine width, and midface hypoplasia correlated with reduced overjet and overbite. Bisphosphonate treatment, especially when initiated before age two, was associated with enamel hypoplasia. Oral hygiene habits, including brushing frequency and use of additional products, were linked to lower DMFT. In the OI group, significant associations were noted between Angle Class III malocclusion and reduced brushing frequency, as well as between deep palatal vault and increased DMFT. A correlation was also observed between maximum mouth opening and joint hypermobility. These findings, along with new dental observations related to non-collagen variants, shed light on the oral health challenges in OI patients. Our study underscores the importance of multidisciplinary collaboration between dentistry and medical genetics in understanding complex conditions like OI. The comprehensive analysis of oral and dental findings in OI cases is expected to inform future research and enhance clinical approaches to managing the dental challenges associated with this disorder.

  • A Rare Inherited Bone Marrow Failure Syndrome Disclosed by Reanalysis of the Exome Data of a Patient Evaluated for Cytopenia and Dysmorphic Features

    by Durmus Durmaz, Ayca Dilruba Aslanger, Zehra Yavas Abali, Yasin Yilmaz, Volkan Karaman, Gozde Yesil Sayin, Guven Toksoy, Aysegul Unuvar, Zehra Oya Uyguner

    Background: Multisystemic findings of inherited bone marrow failure syndromes may cause difficulty in diagnosis. Exome sequencing (ES) helps to define the etiology of rare diseases and reanalysis offers a valuable new diagnostic approach. Herein, we present the clinical and molecular characteristics of a girl who was referred for cytopenia and frequent infections. Case report: A 5-year-old girl with cytopenia, dysmorphism, short stature, developmental delay, and myopia was referred for genetic counseling. Reanalysis of the ES data revealed a homozygous splice-site variant in the DNAJC21 (NM_001012339.3:c.983+1G>A), causing Shwachman-Diamond Syndrome (SDS). It was shown by the RNA sequencing that exon 7 was skipped, causing an 88-nucleotide deletion. Conclusions: Precise genetic diagnosis enables genetic counseling and improves patient management by avoiding inappropriate treatment and unnecessary testing. This report would contribute to the clinical and molecular understanding of this rare type of SDS caused by DNAJC21 variants and expand the phenotypic features of this condition.


  • Open Access

    PROKR2 Mutations in Patients with Short Stature Who Have Isolated Growth Hormone Deficiency and Multiple Pituitary Hormone Deficiency

    by Aslı Derya Kardelen, Adam Najaflı, Firdevs Baş, Birsen Karaman, Güven Toksoy, Şükran Poyrazoğlu, Şahin Avcı, Umut Altunoğlu, Zehra Yavaş Abalı, Ayşe Pınar Öztürk, et al.

    Objective: Recent reports have indicated the role of the prokineticin receptor 2 gene (PROKR2) in the etiology of pituitary hormone deficiencies, suggesting a potential role for the PROK2 pathway in pituitary development, in addition to its role in gonadotropin releasing hormone-expressing neuron development. Here, we present the clinical and molecular findings of four patients with PROKR2 mutations.Methods: Next-generation targeted sequencing was used to screen 25 genes in 59 unrelated patients with multiple pituitary hormone deficiency (MPHD), isolated growth hormone (GH) deficiency, or idiopathic short stature.Results: Two different, very rare PROKR2 missense alterations classified as pathogenic (NM_144773.4:c.518T>G; NP_658986.1:p. (Leu173Arg)) and likely pathogenic (NM_144773.4:c.254G>A; NP_658986.1:p.(Arg85His)) were identified in four patients in heterozygous form. Patient 1 and Patient 2 presented with short stature and were diagnosed as GH deficiency. Patient 3 and Patient 4 presented with central hypothyroidism and cryptorchidism and were diagnosed as MPHD. No other pathogenic alterations were detected in the remaining 24 genes related to short stature, MPHD, and hypogonadotropic hypogonadism. Segregation analysis revealed asymptomatic or mildly affected carriers in the families.Conclusion: PROKR2 dominance should be kept in mind as a very rare cause of GH deficiency and MPHD. Expressional variation or lack of penetrance may imply oligogenic inheritance or other environmental modifiers in individuals who are heterozygous carriers.


  • Clinical and Molecular Findings of Nine Cases with Tay-Sachs Disease From Türkiye

    by Ayça Dilruba Aslanger, Çağrı Güleç, Tuğba Kalaycı, Esma Şengenç, Şahin Avcı, Umut Altunoğlu, Volkan Karaman, Güven Toksoy, Meryem Karaca, Akın İşcan, et al.